Physician profile
Kevin E Jarrell
NPI 1598968117
$1,967.97
in general payments reported to CMS, 2019-2025
24 companies · $47.00 in 2025
The $47.00 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $14.71 · 2021: $430 · 2022: $553 · 2023: $486 · 2024: $121 · 2025: $47.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $468.66 | 2019-2025 | Interlock, Icefx Cryoablation System, Iceforce 2.1 Cx 90 Cryoablation Needle |
| Merck Sharp & Dohme LLC | $152.94 | 2022-2023 | Keytruda |
| Penumbra, INC. | $148.00 | 2021 | |
| Exelixis INC. | $137.21 | 2021-2023 | Cabometyx |
| Eisai INC. | $128.83 | 2019-2023 | |
| Inari Medical, INC. | $120.51 | 2022 | |
| Amgen INC. | $108.10 | 2022-2023 | Lumakras, Vectibix, Xgeva |
| Cook Medical LLC | $106.23 | 2024 | Cook Celect |
| Pharmacyclics LLC, An Abbvie Company | $76.69 | 2021-2023 | Imbruvica |
| Medtronic, INC. | $67.05 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Taiho Oncology, INC. | $60.11 | 2019-2023 | |
| Tesaro, INC. | $58.42 | 2019 | |
| Mirati Therapeutics, INC. | $50.80 | 2023 | Krazati |
| Astrazeneca Pharmaceuticals Lp | $49.74 | 2023 | Lynparza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.32 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $32.02 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $31.94 | 2021-2023 | Denali Vena Cava Filter |
| Bayer Healthcare Pharmaceuticals INC. | $23.79 | 2023 | |
| Terumo Medical Corporation | $22.69 | 2023 | Angio-Seal |
| Becton, Dickinson and Company | $20.75 | 2025 | Pleurx |
| Medtronic USA, INC. | $20.13 | 2019 | |
| Genentech USA, INC. | $18.44 | 2023 | Avastin, Rozlytrek, Tecentriq |
| Seagen INC. | $16.42 | 2022 | |
| Clovis Oncology, INC. | $15.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Jarrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.